Global and United States Rufinamide Market Report & Forecast 2023-2028

Report ID: 1830406 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rufinamide Revenue in Rufinamide Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Rufinamide Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Rufinamide Market Size for the Year 2017-2028
        1.2.2 Global Rufinamide Market Size for the Year 2017-2028
    1.3 Rufinamide Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Rufinamide in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Rufinamide Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Rufinamide Market Dynamics
        1.4.1 Rufinamide Industry Trends
        1.4.2 Rufinamide Market Drivers
        1.4.3 Rufinamide Market Challenges
        1.4.4 Rufinamide Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Rufinamide by Type
    2.1 Rufinamide Market Segment by Type
        2.1.1 Tablets
        2.1.2 Oral suspension
    2.2 Global Rufinamide Market Size by Type (2017, 2022 & 2028)
    2.3 Global Rufinamide Market Size by Type (2017-2028)
    2.4 United States Rufinamide Market Size by Type (2017, 2022 & 2028)
    2.5 United States Rufinamide Market Size by Type (2017-2028)
3 Rufinamide by Application
    3.1 Rufinamide Market Segment by Application
        3.1.1 Adults
        3.1.2 Pediatric patients
    3.2 Global Rufinamide Market Size by Application (2017, 2022 & 2028)
    3.3 Global Rufinamide Market Size by Application (2017-2028)
    3.4 United States Rufinamide Market Size by Application (2017, 2022 & 2028)
    3.5 United States Rufinamide Market Size by Application (2017-2028)
4 Global Rufinamide Competitor Landscape by Company
    4.1 Global Rufinamide Market Size by Company
        4.1.1 Top Global Rufinamide Companies Ranked by Revenue (2021)
        4.1.2 Global Rufinamide Revenue by Player (2017-2022)
    4.2 Global Rufinamide Concentration Ratio (CR)
        4.2.1 Rufinamide Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Rufinamide in 2021
        4.2.3 Global Rufinamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Rufinamide Headquarters, Revenue in Rufinamide Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Rufinamide Headquarters and Area Served
        4.3.2 Global Rufinamide Companies Revenue in Rufinamide Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Rufinamide Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Rufinamide Market Size by Company
        4.5.1 Top Rufinamide Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Rufinamide Revenue by Players (2020, 2021 & 2022)
5 Global Rufinamide Market Size by Region
    5.1 Global Rufinamide Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Rufinamide Market Size by Region (2017-2028)
        5.2.1 Global Rufinamide Market Size by Region: 2017-2022
        5.2.2 Global Rufinamide Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Rufinamide Market Size YoY Growth 2017-2028
        6.1.2 North America Rufinamide Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Rufinamide Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Rufinamide Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Rufinamide Market Size YoY Growth 2017-2028
        6.3.2 Europe Rufinamide Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Rufinamide Market Size YoY Growth 2017-2028
        6.4.2 Latin America Rufinamide Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Rufinamide Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Rufinamide Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Eisai
        7.1.1 Eisai Company Details
        7.1.2 Eisai Business Overview
        7.1.3 Eisai Rufinamide Introduction
        7.1.4 Eisai Revenue in Rufinamide Business (2017-2022)
        7.1.5 Eisai Recent Development
    7.2 Glenmark Pharms
        7.2.1 Glenmark Pharms Company Details
        7.2.2 Glenmark Pharms Business Overview
        7.2.3 Glenmark Pharms Rufinamide Introduction
        7.2.4 Glenmark Pharms Revenue in Rufinamide Business (2017-2022)
        7.2.5 Glenmark Pharms Recent Development
    7.3 Mylan
        7.3.1 Mylan Company Details
        7.3.2 Mylan Business Overview
        7.3.3 Mylan Rufinamide Introduction
        7.3.4 Mylan Revenue in Rufinamide Business (2017-2022)
        7.3.5 Mylan Recent Development
    7.4 West-ward Pharms
        7.4.1 West-ward Pharms Company Details
        7.4.2 West-ward Pharms Business Overview
        7.4.3 West-ward Pharms Rufinamide Introduction
        7.4.4 West-ward Pharms Revenue in Rufinamide Business (2017-2022)
        7.4.5 West-ward Pharms Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Rufinamide Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Rufinamide Market Trends
    Table 3. Rufinamide Market Drivers
    Table 4. Rufinamide Market Challenges
    Table 5. Rufinamide Market Restraints
    Table 6. Global Rufinamide Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Rufinamide Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Rufinamide Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Rufinamide Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Rufinamide Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Rufinamide Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Rufinamide Revenue Share by Player, 2017-2022
    Table 13. Global Rufinamide Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rufinamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rufinamide as of 2021)
    Table 15. Top Players of Rufinamide in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Rufinamide Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Rufinamide Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Rufinamide Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Rufinamide Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Rufinamide Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Rufinamide Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Rufinamide Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Rufinamide Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Rufinamide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Rufinamide Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Rufinamide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Rufinamide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Rufinamide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eisai Company Details
    Table 31. Eisai Business Overview
    Table 32. Eisai Rufinamide Product
    Table 33. Eisai Revenue in Rufinamide Business (2017-2022) & (US$ Million)
    Table 34. Eisai Recent Development
    Table 35. Glenmark Pharms Company Details
    Table 36. Glenmark Pharms Business Overview
    Table 37. Glenmark Pharms Rufinamide Product
    Table 38. Glenmark Pharms Revenue in Rufinamide Business (2017-2022) & (US$ Million)
    Table 39. Glenmark Pharms Recent Development
    Table 40. Mylan Company Details
    Table 41. Mylan Business Overview
    Table 42. Mylan Rufinamide Product
    Table 43. Mylan Revenue in Rufinamide Business (2017-2022) & (US$ Million)
    Table 44. Mylan Recent Development
    Table 45. West-ward Pharms Company Details
    Table 46. West-ward Pharms Business Overview
    Table 47. West-ward Pharms Rufinamide Product
    Table 48. West-ward Pharms Revenue in Rufinamide Business (2017-2022) & (US$ Million)
    Table 49. West-ward Pharms Recent Development
    Table 50. Research Programs/Design for This Report
    Table 51. Key Data Information from Secondary Sources
    Table 52. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rufinamide Product Picture
    Figure 2. Global Rufinamide Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Rufinamide Market Size 2017-2028 (US$ Million)
    Figure 4. United States Rufinamide Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Rufinamide Market Size 2017-2028 (US$ Million)
    Figure 6. United States Rufinamide Market Share in Global 2017-2028
    Figure 7. Rufinamide Report Years Considered
    Figure 8. Product Picture of Tablets
    Figure 9. Product Picture of Oral suspension
    Figure 10. Global Rufinamide Market Share by Type in 2022 & 2028
    Figure 11. Global Rufinamide Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Rufinamide Market Share by Type (2017-2028)
    Figure 13. United States Rufinamide Market Share by Type in 2022 & 2028
    Figure 14. United States Rufinamide Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Rufinamide Market Share by Type (2017-2028)
    Figure 16. Product Picture of Adults
    Figure 17. Product Picture of Pediatric patients
    Figure 18. Global Rufinamide Market Share by Application in 2022 & 2028
    Figure 19. Global Rufinamide Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Rufinamide Market Share by Application (2017-2028)
    Figure 21. United States Rufinamide Market Share by Application in 2022 & 2028
    Figure 22. United States Rufinamide Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Rufinamide Market Share by Application (2017-2028)
    Figure 24. North America Rufinamide Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Rufinamide Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Rufinamide Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Rufinamide Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Rufinamide Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Rufinamide Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Eisai Revenue Growth Rate in Rufinamide Business (2017-2022)
    Figure 53. Glenmark Pharms Revenue Growth Rate in Rufinamide Business (2017-2022)
    Figure 54. Mylan Revenue Growth Rate in Rufinamide Business (2017-2022)
    Figure 55. West-ward Pharms Revenue Growth Rate in Rufinamide Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
Frequently Asked Questions
Rufinamide report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rufinamide report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rufinamide report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Certolizumab Pegol

Certolizumab Pegol market is segmented by region (country), players, by Type and by Application.  ... Read More

Degarelix

Degarelix market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Etravirine

Etravirine market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Lacosamide

Lacosamide market is segmented by region (country), players, by Type and by Application. Players, ... Read More